Related by context. All words. (Click for frequent words.) 75 reinfarction 74 nonfatal MI 74 Erythropoietic therapies may 74 recurrent VTE 73 ipsilateral stroke 73 arterial thromboembolic events 73 thromboembolic events 73 myocardial infarction stroke 73 thromboembolic 72 Hypotension 72 symptomatic VTE 72 TEAEs 72 myocardial infarctions 71 recurrent ischemia 71 prolonged QT interval 71 proximal DVT 71 thromboembolism 71 severe exacerbations 70 extrapyramidal symptoms 70 nonfatal myocardial infarction 70 nonfatal stroke 70 β blockers 70 nonfatal myocardial infarction MI 70 thromboembolic complications 70 VT VF 70 thrombotic events 70 recurrent venous thromboembolism 70 recurrent DVT 70 PRADAXA #mg 70 QTc prolongation 70 periprocedural 70 hypoglycemic events 70 cardiovascular hospitalizations 69 revascularization procedures 69 myocardial infarction MI 69 Stent thrombosis 69 HF hospitalization 69 events MACE 69 neurologic complications 69 upper gastrointestinal bleeding 69 ventricular fibrillation VF 69 torsade de pointes 69 hypoglycemic episodes 69 MACCE 69 torsades de pointes 69 hematologic toxicity 69 hemorrhagic complications 69 coronary revascularization 69 NATRECOR R 69 Severe hypoglycemia 69 cardiovascular hospitalization 69 postoperative AF 69 refractory ischemia 69 macrovascular events 68 revascularizations 68 VIIBRYD 68 ventricular tachycardia VT 68 rhythm disturbances 68 composite endpoint 68 ischemic complications 68 non valvular atrial 68 morphometric vertebral fractures 68 reoperations 68 NYHA Class II 68 postoperative mortality 68 eplerenone 68 repeat revascularization 68 hyperkalemia 68 postoperative complication 67 left ventricular dysfunction 67 Febrile neutropenia 67 intima media thickness 67 resuscitated cardiac arrest 67 sustained ventricular tachycardia 67 myocardial ischemia 67 atrioventricular block 67 venous thromboembolisms 67 ICD shocks 67 variant angina 67 carotid stenosis 67 ventricular arrhythmia 67 glycated hemoglobin levels 67 intravitreal injections 67 primidone 67 hypoglycaemic episodes 67 ATACAND 67 Postoperative complications 67 beta blocker therapy 67 postoperative bleeding 67 silent ischemia 67 LV dysfunction 67 asymptomatic carotid stenosis 67 gastrointestinal perforation 67 resynchronization therapy 67 systemic embolism 67 cytopenias 67 dysrhythmias 67 nonischemic 67 perioperative mortality 67 noncardiac 67 antithrombotic therapy 67 NATRECOR ® 67 ximelagatran 67 fatal myocardial infarction 67 NNT = 67 EXJADE 67 cilostazol 67 pericardial effusion 67 aminotransferases 67 thrombotic complications 66 hypomagnesemia 66 tachyarrhythmias 66 carotid artery blockage 66 electrical cardioversion 66 rebleeding 66 LVSD 66 binary restenosis 66 definite stent thrombosis 66 renal dysfunction 66 ARCOXIA 66 perioperatively 66 IIIa inhibitor 66 nonvertebral fracture 66 intracranial bleeding 66 ventricular tachyarrhythmia 66 QTc intervals 66 death reinfarction 66 revascularisation 66 nadolol 66 androgen deprivation 66 arterial occlusion 66 venous thromboembolic events 66 leucopenia 66 ECG abnormalities 66 PRADAXA 66 PASI scores 66 noncardiac surgery 66 thromboses 66 DES implantation 66 intracerebral hemorrhage 66 QT prolongation 66 coronary stenosis 66 ventricular tachyarrhythmias 66 fibrinolysis 66 CHD CVD 66 gastrointestinal bleeds 66 artery stenosis 66 laboratory abnormalities 66 cerebral vasospasm 66 PLX STROKE targeting 66 symptomatic intracranial 66 thyrotoxicosis 66 oxycodone CR 66 Infusion Reactions Severe 66 gout flares 66 concomitant medications 66 tirofiban 66 ticlopidine 66 RLAI 66 hemodynamic instability 66 Events MACE 66 ischemia driven 66 paroxysmal AF 66 decompensated heart failure 66 cardioembolic stroke 65 hepatotoxicity 65 syncopal 65 postoperative atrial fibrillation 65 severe hypoglycemic 65 Torsades de Pointes 65 intracerebral haemorrhage 65 QTc interval 65 clinically meaningful reductions 65 intracerebral hemorrhages 65 nasopharyngitis headache 65 ischemic cardiomyopathy 65 lumiracoxib 65 nonvertebral fractures 65 myocardial infarction ventricular fibrillation 65 acute decompensation 65 QTc 65 HbA 1c levels 65 infarctions 65 systemic corticosteroid 65 aldosterone antagonist 65 antiplatelet drugs 65 intravenous bisphosphonates 65 FluCAM arm 65 cerebrovascular accident 65 coronary revascularization procedures 65 electrolyte abnormalities 65 overt nephropathy 65 Tasigna prolongs 65 postprocedure 65 Thal Dex 65 colorectal adenoma 65 spinal cord compression 65 rFVIIa 65 hyperacute 65 QT interval prolongation 65 severe hypoglycemia 65 deep vein thromboses 65 QTcF 65 neurologic symptoms 65 ALT flares 65 transaminase elevations 65 platelet reactivity 65 unstable angina pectoris 65 cardiovascular ischemic 65 nondiabetic patients 65 stroke transient ischemic 65 valvular disease 65 androgen suppression 65 nonfatal cardiovascular 65 Hemorrhagic strokes 65 cardiac dysfunction 65 idraparinux 65 apnea hypopnea 65 anticoagulants blood thinners 65 subtrochanteric 65 cerebral infarction 64 receiving XGEVA 64 antithrombotic therapies 64 intensive statin therapy 64 mcg QD 64 recurrent myocardial infarction 64 fatal pulmonary embolism 64 target vessel revascularization 64 clopidogrel Plavix 64 Ventricular tachycardia 64 nadroparin 64 intravenous diuretics 64 antiarrhythmic drugs 64 receiving VELCADE 64 hyperglycaemia 64 aspirin clopidogrel 64 myocardial infarctions MIs 64 Pulmonary embolism 64 events TEAEs 64 advanced adenoma 64 aortic regurgitation 64 myocardial infarction 64 acute coronary syndromes ACS 64 rosuvastatin #mg 64 postoperative morbidity 64 microvascular complications 64 pulmonary artery catheterization 64 vasospasm 64 eptifibatide 64 unfractionated heparin 64 hyperalgesia 64 intraoperative complications 64 NSTEMI 64 coronary intervention 64 cerebrovascular accidents 64 dopaminergic therapy 64 subclinical hypothyroidism 64 atherothrombotic events 64 hypoperfusion 64 noncardiovascular 64 MIRAPEX 64 patients undergoing CABG 64 atrial tachyarrhythmias 64 severe neutropenia 64 BYSTOLIC 64 pyrexia mucositis sepsis febrile 64 symptomatic pulmonary embolism 64 nonfatal pulmonary embolism 64 adrenal insufficiency 64 biologic DMARD 64 simvastatin ezetimibe 64 serum phosphorous 64 oxygen desaturation 64 CVD mortality 64 asymptomatic PAD 64 anticlotting drugs 64 noncardiovascular mortality 64 bypass graft CABG surgery 64 venous thromboembolism 64 Avandia Actos 64 hypocalcemia 64 Ileus 64 underwent coronary angiography 64 pamidronate 64 UA NSTEMI 64 otamixaban 64 microvascular disease 64 infarct size 64 claudication 64 thromboprophylaxis 64 bradycardia 64 bezafibrate 64 HbA1C levels 64 hypoxemia 64 FRAGMIN 64 generalized seizures 64 conjunctival hyperemia 64 myopathy rhabdomyolysis 64 thromboembolic disease 64 serum aminotransferase levels 64 hypotension 64 subarachnoid hemorrhages 64 ropivacaine 64 inhospital 64 virologic failure 63 perioperative complications 63 atherothrombotic disease 63 renal flares 63 induce orthostatic hypotension 63 microalbuminuria 63 ventricular arrhythmias 63 asystole 63 variceal bleeding 63 variceal hemorrhage 63 Myocardial infarction 63 coronary stenoses 63 postoperative infections 63 ventricular dysfunction 63 valvulopathy 63 neurologic sequelae 63 intravenous cyclophosphamide 63 thrombolytic therapy 63 carotid artery stenosis 63 NYHA functional class 63 untreated OSA 63 ventricular repolarization 63 neuropsychiatric symptoms 63 pretest probability 63 haemorrhagic strokes 63 nesiritide 63 macrovascular disease 63 valve regurgitation 63 salmeterol HFA MDI 63 carotid atherosclerosis 63 CrCl 63 deep venous thromboses 63 COPD exacerbation 63 STRIDE PD 63 syncope fainting 63 mcg BID 63 Pulmonary Embolism PE 63 Venous thromboembolism 63 generalized edema 63 TMP SMX 63 stenoses 63 atrial arrhythmias 63 renal insufficiency 63 coronary interventions 63 pulmonary embolism PE 63 ocular adverse 63 MIs 63 Unstable angina 63 serum creatinine levels 63 endophthalmitis 63 pulmonary toxicity 63 urate lowering therapy 63 discontinuations due 63 hypophosphatemia 63 loop diuretics 63 tachyarrhythmia 63 Hemorrhagic stroke 63 Treatment emergent adverse 63 oral antidiabetic medication 63 neurologic deficits 63 hypercalcemia 63 undergoing CABG 63 onset atrial fibrillation 63 HAM D# scores 63 postintervention 63 pioglitazone 63 dermatologic reactions 63 neutropenia dehydration dyspnea 63 elevated IOP 63 Peripheral edema 63 corticosteroid therapy 63 β blocker 63 aneurysmal subarachnoid hemorrhage 63 PSA nadir 63 chronic thromboembolic pulmonary 63 argatroban 63 angiotensin converting enzyme inhibitor 63 tenecteplase 63 systolic dysfunction 63 NYHA Class III 63 cardiac resynchronization 63 amiodarone 63 AVANDIA 63 post thrombotic syndrome 63 tolvaptan 63 lipid lowering agents 63 CYPHER Stent 63 hypoventilation 63 Thrombocytopenia 63 MULTAQ 63 AGILECT R 63 tapentadol ER 63 CTEPH 63 p = NS 63 symptomatic hyponatremia 63 bolus dose 63 asthma exacerbation 63 pacemaker implantation 63 lower extremity amputation 63 irbesartan 63 LVEF 63 nontraumatic 63 neutrophil counts 63 systemic hypotension 63 Peripheral arterial disease 63 Thrombotic events 63 angiographic outcomes 63 enoxaparin 63 stent thromboses 63 ruboxistaurin 63 sotalol 63 acute myocardial infarctions 63 ezetimibe simvastatin 63 x ULN 63 stent implantation 63 femoral neck fracture 63 venous thromboembolic disease 63 EDSS scores 63 teriflunomide 63 PAOD 63 olmesartan 63 systolic hypertension 63 beta blockers ACE inhibitors 63 cardiac repolarization 63 SCr 63 advanced adenomas 63 APTIVUS r 63 nonadherence 63 milrinone 63 ARIXTRA 63 malperfusion 63 acute coronary 63 glomerular filtration 63 artery occlusion 63 adrenal suppression 62 troponin T 62 lipid lowering drugs 62 repolarization 62 primary percutaneous coronary 62 conventional angiography 62 aldosterone antagonists 62 hemoglobin A1c levels 62 paresthesias 62 thrombophlebitis 62 white matter hyperintensities 62 hippocampal atrophy 62 arteriography 62 baseline HbA1c 62 octreotide LAR 62 undergoing coronary artery 62 Thrombolysis 62 pericardial effusions 62 intra abdominal abscess 62 optic neuropathy 62 recurrent coronary 62 gastrointestinal perforations 62 cardiac tamponade 62 unresectable HCC 62 discontinuations 62 percutaneous coronary interventions 62 adjunctive ABILIFY 62 TAVR 62 Hazard Ratio = 62 Serious adverse reactions 62 bypass grafting 62 gadobutrol 62 paroxysmal atrial fibrillation 62 venous thrombosis 62 acute myocardial infarction AMI 62 severe hypoglycaemia 62 cystoid macular edema 62 MIRAPEX ER 62 P = .# 62 loop diuretic 62 mild renal impairment 62 thrombo embolic 62 timepoints 62 macrovascular 62 cytogenetic abnormalities 62 biochemical recurrence 62 vertebral fracture 62 unexplained syncope 62 nonhematologic adverse reactions 62 asthma exacerbations 62 pathologic fractures 62 adjunctive placebo 62 TAXUS Stent 62 treatment emergent adverse 62 endometrial hyperplasia 62 proliferative retinopathy 62 tardive dyskinesia TD 62 lenalidomide dexamethasone 62 urate lowering 62 coronary insufficiency 62 hepatorenal syndrome 62 Brugada syndrome 62 ejection fractions 62 ischemic cardiovascular 62 bisoprolol 62 recurrent atrial fibrillation 62 tamsulosin 62 anticoagulant medications 62 glycoprotein IIb IIIa inhibitor 62 atypical fractures 62 anastomotic leak 62 hematological toxicity 62 insulin detemir 62 hyperprolactinemia 62 acute ischemic 62 PSADT 62 status epilepticus 62 chemoradiotherapy 62 leukopenia 62 angioplasty stenting 62 ICD implants 62 certolizumab 62 HbA 1c 62 enalapril 62 syncope 62 neurologic outcomes 62 paclitaxel eluting stents 62 Severe acneform rash 62 salpingo oophorectomy 62 anemia neutropenia 62 nicardipine 62 antiplatelet medications 62 cardiovascular mortality 62 hematological adverse 62 FOLPI 62 left ventricular systolic 62 NIHSS score 62 urine albumin 62 Subarachnoid hemorrhage 62 lymphopenia 62 lactic acidosis 62 malignant neoplasm 62 Operative mortality 62 autonomic dysfunction 62 elective PCI 62 hyperparathyroidism 62 hematologic adverse 62 #mmHg [001] 62 orthostatic hypotension 62 #.#/#.# mmHg [001] 62 ventricular tachycardia 62 postoperative pulmonary 62 postoperative complications 62 ischemic cerebrovascular 62 TNF antagonist 62 intravascular hemolysis 62 Hb A1C 62 dobutamine 62 hypokalemia 62 symptomatic carotid stenosis 62 febrile neutropenia 62 hepatic enzymes 62 infarcts 62 neutropenia thrombocytopenia 62 elevated liver enzymes 62 thrombolytic agents 62 Known hypersensitivity 62 PREZISTA r arm 62 patients undergoing percutaneous 62 alanine aminotransferase 62 glycosylated hemoglobin HbA1c 62 renal artery stenosis 62 pulmonary dysfunction 62 peri procedural 62 Ischemic strokes 62 moderate renal impairment 62 tumor lysis syndrome 62 TAXUS p value 62 LV ejection fraction 62 microbleeds 62 postoperative chemotherapy 62 cholecystitis 62 cryptogenic stroke 62 locoregional recurrence 62 hsCRP levels 62 Ventricular Tachycardia 62 reblockage 62 pulmonary exacerbations 62 perfusion defects 62 intracranial atherosclerosis 62 headache nausea diarrhea 62 D dimer 62 paroxetine Paxil 62 aneurysm rupture 62 cerebral ischemia 62 rhythm abnormalities 62 poor metabolizers 62 XIENCE V PROMUS Stent 62 haematologic 62 heparin induced thrombocytopenia 62 tricuspid regurgitation 62 reintervention 62 glycated hemoglobin HbA1c 62 renal scarring 62 lightheadedness fainting 62 NYHA class 62 coadministration 61 intracranial hemorrhage ICH 61 MI myocardial infarction 61 hemorrhagic strokes 61 clopidogrel therapy 61 anaphylactic reactions bronchospasm 61 arterial stiffening 61 lipid lowering therapy 61 mycophenolate mofetil 61 prednisone prednisolone 61 atorvastatin #mg 61 percutaneous intervention 61 periprocedural MI 61 lacunar 61 prespecified secondary 61 incidence ≥ 61 angina chest 61 unstable angina 61 pulmonary artery banding 61 circulating EPCs 61 carotid endarterectomy CEA 61 INVEGA ® 61 postoperative hemorrhage 61 severe renal impairment 61 retransplantation 61 atherogenic dyslipidemia 61 syndrome OSAS 61 stable angina 61 prostate TURP 61 fractional shortening 61 poststroke 61 thrombolytics 61 peripheral arterial occlusive disease 61 % AST SGOT 61 Hypocalcemia 61 symptom exacerbation 61 endometrial carcinoma 61 confidence interval #.#-#.# 61 proliferative diabetic retinopathy 61 malignant neoplasms 61 thrombocytopenic 61 sinus node dysfunction 61 severe hypersensitivity reactions 61 fondaparinux 61 NPH insulin 61 Arrhythmias 61 OSAHS 61 biventricular pacing 61 hypertension diabetes mellitus 61 neurologic dysfunction 61 anaphylactoid reactions 61 cerebral perfusion 61 Subgroup analysis 61 symptomatic atrial fibrillation 61 NIASPAN 61 ALT elevations 61 preserved ejection fraction 61 VTE prophylaxis 61 antiarrhythmic drug 61 Lamictal XR 61 Cardiopulmonary bypass 61 benazepril 61 carotid IMT 61 Toxicities 61 myocardial reperfusion 61 myoclonus 61 mitral stenosis 61 cerebral microbleeds 61 antiepileptic medications 61 sinus bradycardia 61 Carotid endarterectomy 61 receiving VICTRELIS 61 conventional antipsychotics 61 stroke myocardial infarction 61 transurethral resection 61 somnolence dizziness 61 symptomatic DVT 61 nonobstructive CAD 61 angina pectoris 61 Fluid retention 61 rt PA 61 nephrotoxicity 61 REYATAZ r arm 61 bivalirudin 61 myocardial fibrosis 61 ibandronate 61 glycoprotein IIb IIIa inhibitors 61 full thickness plication 61 plus methotrexate 61 elevated triglyceride levels 61 COREG 61 unfractionated heparin UFH 61 neutropenia febrile neutropenia 61 VAPRISOL 61 varicella infection 61 oral hypoglycemic agents 61 dalteparin 61 T2 lesions 61 defibrillator CRT D 61 anti arrhythmic drugs 61 VADT 61 intracranial stenosis 61 haloperidol Haldol 61 angiotensin converting enzyme inhibitors 61 renal toxicity 61 MADRS score 61 gastrointestinal toxicity 61 nonsignificant 61 neutropaenia 61 typical antipsychotics 61 ischemic lesions 61 pulmonary embolus 61 acute aortic dissection 61 neurocognitive deficits 61 reinterventions 61 PSVT 61 mucocutaneous reactions 61 intraventricular hemorrhage 61 transcatheter closure 61 HbA1c levels 61 events AEs 61 headache nasopharyngitis 61 pulmonary capillary wedge 61 constipation nausea 61 venlafaxine Effexor 61 nocturnal hypoglycemia 61 recombinant tissue plasminogen 61 Nesiritide 61 urgent coronary revascularization 61 somatostatin analog 61 multivariate adjustment 61 bone marrow suppression 61 somnolence sedation 61 hemodynamically significant 61 nonfasting triglyceride levels 61 bowel perforations 61 daytime drowsiness 61 gastrointestinal toxicities 61 thrombocytopenia neutropenia 61 nonaspirin 61 antithrombotics 61 CABG surgery 61 Severe hypersensitivity reactions 61 cerebrovascular 61 hemoptysis 61 cardiac conduction 61 anemia hemoglobin 61 achieved ACR# 61 #mm Hg 61 wound dehiscence 61 salmeterol fluticasone 61 pulmonary artery hypertension 61 hip BMD 61 Primary endpoints 61 sulphonylureas 61 diastolic blood pressures 61 fluvastatin 61 fibrinolytic 61 hypercholesterolaemia 61 extrapyramidal symptoms EPS 61 riociguat 61 hepatic failure 61 nonoperative treatment 61 solifenacin 61 intraventricular 61 corrected QT interval 61 obstructive CAD 61 embolic stroke 61 recurrent glioblastoma multiforme 61 5-FU/LV 61 postop 61 XIENCE V demonstrated 61 dysglycemia 61 Critical limb ischemia 61 AST ALT 61 plus GP IIb 61 lymphocytosis 61 retinal vein occlusion 61 pulmonary exacerbation 61 fasting triglycerides 61 brivaracetam 61 graft dysfunction 61 hepatic toxicity 61 hypersensitivity reaction 61 AGGRASTAT ® tirofiban hydrochloride 61 MMSE score 61 ACTOplus met 61 Crohn Disease Activity 61 DAPT 61 ventricular remodeling 61 macroalbuminuria 61 mild renal insufficiency 61 budesonide pMDI 61 mL/min/#.# m 2 61 alteplase 61 serum triglycerides 61 CI #.#-#.# [001] 61 Eisenmenger syndrome 61 QRS duration 61 ecchymosis 61 underwent CABG 61 EEG abnormalities 61 venous blood clots 61 Mitral regurgitation 61 ictal 61 PR interval prolongation 61 metformin accumulation 61 cardiogenic shock 61 zolmitriptan 61 reteplase 61 dopamine antagonists 61 Daytime sleepiness 61 variceal 60 aspartate aminotransferase 60 preoperative chemotherapy 60 postoperative radiotherapy 60 serum potassium 60 Subgroup analyzes 60 oral corticosteroids 60 peripheral sensory neuropathy 60 Atrial flutter 60 GP IIb IIIa inhibitors 60 antiarrhythmic medications 60 severe asthma exacerbations 60 hemodilution 60 adrenalectomy 60 parkinsonian symptoms 60 concomitant AEDs 60 lumbar spine BMD 60 extubation 60 HMG CoA reductase inhibitors 60 Atacand 60 GnRH agonist 60 valvular heart disease 60 vasogenic edema 60 unstable angina UA 60 fluticasone salmeterol 60 echocardiographic 60 detrusor overactivity 60 warfarin sodium 60 mitral insufficiency 60 levodopa therapy 60 dyssynchrony 60 clinically meaningful improvement 60 inotropic 60 SUVmax 60 heart palpitations dizziness 60 Ventricular fibrillation 60 #mg BID [003] 60 denervation 60 symptomatic intracranial hemorrhage 60 elevated ALT 60 primary generalized tonic 60 lopinavir r arm 60 liver transaminases 60 pulsatile flow 60 metabolic parameters 60 tibolone 60 mg kg dose 60 bronchospasm 60 jugular venous 60 occlusive disease 60 neutropenic sepsis 60 predisposing factor 60 ticagrelor 60 QT intervals 60 oral antidiabetes 60 ruptured aneurysms 60 coronary blockages 60 antipsychotic efficacy 60 cardiovascular 60 ICD implantation 60 myalgia arthralgia 60 elevated serum creatinine 60 CK MB 60 recurrent wheezing 60 myocardial necrosis 60 HPA axis suppression 60 BENICAR HCT 60 capillary leak 60 SGPT 60 pump CABG 60 DLTs 60 GP IIb IIIa inhibitor 60 apnea hypopnea index 60 analgesic medications 60 recanalization 60 comparator arm 60 diabetic kidney 60 symptomatic hypotension 60 elevated bilirubin 60 confidence interval CI 60 atheroma volume 60 ACTOplus met XR 60 IELT 60 failure NYHA 60 ipsilateral 60 oral antidiabetic drugs 60 SRBD 60 aspartate aminotransferase AST 60 urolithiasis 60 corticosteroid dose 60 afterload 60 non selective NSAIDs 60 Clinically significant 60 frequent awakenings 60 antihypertensive medications 60 preintervention 60 postural hypotension 60 antihypertensive agents 60 dronedarone 60 nausea dizziness vomiting 60 elevated transaminases 60 CRT Ds 60 nonmelanoma skin cancers 60 histologic subtype 60 capillary leakage 60 confirmed thrombotic cardiovascular 60 neurological complications 60 nonfatal heart 60 Renal impairment 60 artery reclogging 60 incontinence episodes 60 clinically detectable 60 angina myocardial infarction 60 verapamil 60 percutaneous interventions 60 bronchial hyperresponsiveness 60 PROMACTA 60 EFFEXOR XR 60 tension pneumothorax 60 prophylactic therapy 60 fibrosis scarring 60 serum cortisol 60 Renal dysfunction 60 venous thrombotic events 60 abacavir lamivudine 60 valsartan 60 baseline FEV 60 peripheral edema 60 hyperphenylalaninemia HPA due 60 angioplasties stents 60 HBeAg negative patients 60 gadolinium enhanced 60 serum sodium 60 nasopharyngitis 60 ADHF 60 serum calcium levels 60 anticoagulation therapy 60 superficial femoral 60 left ventricular hypertrophy 60 Anaphylactic reactions 60 hyperintensity 60 #mg/day [002] 60 IOP lowering 60 treatment emergent AEs 60 Postoperatively 60 lacosamide 60 lipid lowering medications 60 tipranavir r 60 fibrinolytic therapy 60 aortic insufficiency 60 deep venous thrombosis 60 intermittent claudication 60 thyrotropin levels 60 intravascular ultrasonography 60 gastrointestinal reflux 60 lamotrigine 60 uncoated stent 60 epistaxis 60 Sleep disturbances 60 spirometric 60 concomitant antibiotics 60 TAXUS Express Stent 60 GnRH agonists 60 tiagabine 60 parecoxib 60 coronary artery stenosis 60 biochemical relapse 60 bivalirudin monotherapy 60 PNH patients 60 acute hepatic 60 juvenile idiopathic arthritis 60 fluid overload 60 #Gy 60 catheter angiography 60 clazosentan 60 PEGINTRON TM 60 antiplatelet medication 60 Uncontrolled hypertension 60 LAGB 60 AGILECT ® 60 primary aldosteronism 60 neurodevelopmental impairment 60 placebo dexamethasone